where does glp 1 drug come from Study finds GLP-1 receptor agonists target fat over muscle for weight loss New GLP-1 Guidelines for Type
Description
Tschp, Timo D

Results Patient population We included 78,781 patients who had both a prescription for a GLP-1 receptor agonist (GLP-1 RA) and a documented reason for discontinuing the medication between June 2021 and December 2024 (Table 1)

[DOI] [PubMed] [Google Scholar] 76.Steven S., Oelze M., Hanf A., Kroller-Schon S., Kashani F., Roohani S., Welschof P., Kopp M., Godtel-Armbrust U., Xia N., et al

doi: 10.1056/NEJMoa2107519 48 LudvikBGiorginoFJdarEFriasJPFernndez LandLBrownKet al

There may, of course, be individual reasons why a person with type 2 diabetes and CKD might benefit from incretin mimetics
LY3463251 is the first GDF-15 agonist that has completed a phase 1 clinical trial WL was 3% after a 12-week treatment period [100]